1. Home
  2. News
  3. LISAvienna event on the occasion of ViennaUP‘22: Photo gallery and slides
Back to overview
Artboard 11

LISAvienna event on the occasion of ViennaUP‘22: Photo gallery and slides

We thank our speakers for their presentations and are happy that about 250 guests followed our invitation to network at Kursalon Hübner on May 31, 2022.

Together with Biotech Austria and EIT Health Austria we organized an event focusing on life science funding opportunities that facilitate developing ideas into new marketable products, processes and services in Vienna. Our guests enjoyed discussing the programs available at AWS, FFG, the Vienna Business Agency and at the international level, including EIT Health. In addition to start-ups and companies from Vienna, also international ViennaUP participants joined the event and strengthened their contacts to funding agencies, investors, service providers and academic institutions.

ViennaUP is a decentralized community-driven festival. It was the first year with in-person events. To provide the Vienna Business Agency with feedback on ViennaUP'22 in general, please follow this link so we can keep improving: https://technopolis.limequery.com/743537?token=GQ9UvPAR11

Download presentation documents:

Networking opportunity: LISAvienna’s 20th anniversary

We cordially invite you to celebrate our anniversary and Vienna’s successful life science sector. Register soon! We are looking forward to welcoming you at the Vienna City Hall on September 27, 2022.

Photo gallery

Image 1 from 85
Image 2 from 85
Image 3 from 85
Image 4 from 85
Image 5 from 85
Image 6 from 85
Image 7 from 85
Image 8 from 85
Image 9 from 85
Image 10 from 85
Image 11 from 85
Image 12 from 85
Image 13 from 85
Image 14 from 85
Image 15 from 85
Image 16 from 85
Image 17 from 85
Image 18 from 85
Image 19 from 85
Image 20 from 85
Image 21 from 85
Image 22 from 85
Image 23 from 85
Image 24 from 85
Image 25 from 85
Image 26 from 85
Image 27 from 85
Image 28 from 85
Image 29 from 85
Image 30 from 85
Image 31 from 85
Image 32 from 85
Image 33 from 85
Image 34 from 85
Image 35 from 85
Image 36 from 85
Image 37 from 85
Image 38 from 85
Image 39 from 85
Image 40 from 85
Image 41 from 85
Image 42 from 85
Image 43 from 85
Image 44 from 85
Image 45 from 85
Image 46 from 85
Image 47 from 85
Image 48 from 85
Image 49 from 85
Image 50 from 85
Image 51 from 85
Image 52 from 85
Image 53 from 85
Image 54 from 85
Image 55 from 85
Image 56 from 85
Image 57 from 85
Image 58 from 85
Image 59 from 85
Image 60 from 85
Image 61 from 85
Image 62 from 85
Image 63 from 85
Image 64 from 85
Image 65 from 85
Image 66 from 85
Image 67 from 85
Image 68 from 85
Image 69 from 85
Image 70 from 85
Image 71 from 85
Image 72 from 85
Image 73 from 85
Image 74 from 85
Image 75 from 85
Image 76 from 85
Image 77 from 85
Image 78 from 85
Image 79 from 85
Image 80 from 85
Image 81 from 85
Image 82 from 85
Image 83 from 85
Image 84 from 85
Image 85 from 85

Contact

Brigitte Tempelmaier
Communications Manager
T +43 676 85 19 40 403
tempelmaier@LISAvienna.at

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.

You may also be interested in these news


Biomay obtains FDA approval for manufacturing of Cas9 nuclease at headquarters site

The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing,…

BOKU: Pflanzliche Glykobiologie: Neue Erkenntnisse über das molekulare Wettrüsten zwischen Pflanzen und Krankheitserregern

Forschende der BOKU University haben gemeinsam mit internationalen Partnern einen bislang unbekannten Abwehrmechanismus…

Pharmig: Schutz des geistigen Eigentums stärkt Medikamentenentwicklung in Europa

Ein starker Patentschutz ist eine zentrale Voraussetzung für Arzneimittelforschung und neue Therapien. Lockerungen…

All news